About Us

Terpenia Phytotherapeutics produces organic full-spectrum cannabis extracts in Alistrati, Serres in northern Greece. We provide a high quality end-product that is flexible and safe to dose due to its constant active ingredient content.

Our mission

“One’s destination is never a place, but a new way of seeing things.”

Henry Miller

Terpenia’s cultivation and production facility is located in Northern Greece, in the prefecture of Serres. The region is located in the warm temperate zone (subtropics), where the Mediterranean climate is characterized by humid-mild winters and dry-hot summers. Such a climate turns out to be ideal for the cultivation of the cannabis plant. This is where we grow our high quality, purely ecological cannabis.

Through an advanced extraction process, we minimize the loss of volatile and fragile compounds and thus gain a broader spectrum of pharmacologically valuable terpenes. Our end-product contains a complex and rich palette of oils and flavors compared to other medical cannabis products. Our extraction process minimizes the risk of biological contamination, such as fungal spores or bacteria. A very low water activity (aw) value assures no subsequent microbial growth and eliminates the need for post processing like irradiation treatment.

Our end-products adhere to all relevant European laws and regulations for the production of pharmaceutical and herbal medicinal products.

All our cultivation, production and distribution activities follow strict EU regulations and good practice guidelines, such as: Good Manufacturing Practice (GMP), Good Agricultural and Collecting Practice (GACP) , Good Distribution Practice (GDP), Good manufacturing practice for active pharmaceutical ingredients (ICH Q7A). 

100% Sustainability: Our Promise & Values

At the core of all our operations is our  environmental code of conduct that guides our research & production and aims to consistently integrate ecological, social and knowledge management aspects into our activities.

Sustainable Methods

Despite being significantly more labor intensive, we choose traditional building and manual cultivation methods over industrial techniques. Our facility is built with ecological materials, mainly wood and glass and is powered entirely by renewables, such as solar and wind energy.

Conservative use of resources

We water our plants manually and individually to avoid the high water consumption of automated irrigation systems. Furthermore, our plants grow entirely with available sunlight and do not require any artificial lighting in our advanced glass greenhouse.

Ecological production

We use purely organic fertilisers and our extraction process is executed with strictly natural, non-toxic substances.  We pay close attention to our production process and make sure not to emit any environmentally harmful substances.


Research Funding

We allocate 10% of our profits to our own research projects, as well as to other promising research & development projects in the field of medical cannabis.


Social Engagement

We intend to allocate 5% of our profits to school-projects, scholarships, and local charitable and environmental projects.

Job Opportunities

We create direct employment opportunities in facility administration and cultivation.

Our roadmap

“The Path is made by walking. By walking you make a path.

Antonio Machado


Greece approves laws allowing the export of cannabis flowers and extracts.


  • Official company founding
  • Cultivation permits for medical cannabis in Greece
  • Negotiations with new investors and partners


We plan our farming and production enterprise in Greece and seek new partners for research & development.


  • New Partners: Research agreement with the University Hospital Bonn
  • Establishing our Production Site in Alistrati – Serres
  • Full-fledged team recruit


The Greek Parliament introduces law 4523/2018, authorizing the cultivation and processing of medical cannabis.


  • Clarification process of the legal framework for the cultivation of medical cannabis in Greece and the export for sales and research purposes within the EU


Meet Our Team

Our team consists of internationally acclaimed experts from the
fields of medicine, molecular biomedicine and botany.

Dr. rer. nat. Pavlos Kokordelis

Dr. rer. nat. Pavlos Kokordelis

CEO | Molecular Biomedicine


Dr. Kokordelis obtained his doctorate in molecular biomedicine and has led a research group in human genetics at the University Hospital Bonn.

He is a certified project manager in accordance with Section 15 (4) of the Genetic Engineering Safety Ordinance and a certified GMP specialist.

He has several years of experience in personnel- and project management, as well as in international sales and public relations. He is a member of the German Society for Immunology (DGfI) and the German Center for Infection Research (DZIF).

Dr. rer. nat. Jan Papies

Dr. rer. nat. Jan Papies

Head of Basic Research | Molecular Biology


Dr. Papies is an expert on emerging viral diseases and immunology. He was awarded a doctorate in molecular biology for his studies on the immunologic aspects of stress and viral infections.

He advanced his research as post-doctoral scientist at Charité University Hospital Berlin, focusing on host-targeting antivirals and immune modulation. These studies included phytomedical approaches against SARS-CoV-2 infection and inflammation.

Dr. Papies is specialized in advanced cell culture model systems and assay development.

Dr. rer. nat. Filip Fuchs

Dr. rer. nat. Filip Fuchs

Head of Production | Molecular Botany


Dr. Fuchs received his doctorate in botany from the Rheinische Friedrich-Wilhelms-Universität Bonn and was part of the department of cellular and molecular botany (IZMB).

In his studies he focused on plant physiology and plant microbe interaction. He has several years of experience in plant growing and biological pest control.

Dr. Fuchs also holds a M.Sc. in microbiology with a focus on applied microbiology and is a certified GMP specialist.

Dr. Maria Teresa Romano

Dr. Maria Teresa Romano

Scientific Board | NGS


Dr. Maria Teresa Romano has a PhD in Experimental Medicine from the Institute of Human Genetics, University of Bonn.

Her doctoral research focused on the study of rare monogenic hair loss disorders, resulting in the successful identification and characterization of a new gene for Hereditary Hypotrichosis.

Dr. Romano has gained numerous years of experience in molecular genetics and NGS-data analysis and interpretation, with particular focus on clinical genetics.

Dr. Romano also holds a double M.Sc. in Biomedical sciences.

Prof. Dr. med. Jürgen K. Rockstroh

Prof. Dr. med. Jürgen K. Rockstroh

Scientific & Medical Board | Medicine


Prof. Dr. med. Rockstroh is a specialist in internal medicine and  infectious diseases.

He has been serving as the head of the Infectious Diseases & Immunology Department at the University Hospital Bonn since 1998. His areas of expertise include HIV and hepatitis.

He is a board member of the European AIDS Society and chairman of EuroTEST.

He has been the President of the European AIDS Society (2019-20) and a board member of the International AIDS Society (2011-2020).

His research has so far been published in over 700 articles.

Dr. Aylar Tafazzoli ‍

Dr. Aylar Tafazzoli ‍

Scientific Board | Complex Genetics


Dr. Aylar Tafazzoli earned her PhD in Human Genetics at the University of Bonn.

Her doctoral research was concerned with the functional characterization of novel disease genes of various complex disorders and the involvement of epigenetic factors.

Dr. Tafazzoli has gained significant knowledge of processing high-throughput omics data as well as genotype-phenotype correlation analyses which are at the basis of pharmacogenetic research.

Dr. Tafazzoli also holds a M.Sc. in Medical Biology and Genetics.

Dr. rer. nat. Wolfram Lobin

Dr. rer. nat. Wolfram Lobin

Scientific Board | Botany


Dr. Lobin is a specialist in island floras and plants of the Caucasus.

He was the curator of the Botanical Gardens of the Rheinische Friedrich-Wilhelms-Universität Bonn (1987- 2016).

His doctorate was concerned with the “Biogeographical Position of the Cape Verde Islands”. Among other places, he undertook numerous research trips to Greece.

Dr. Lobin was a spokesman for the German curators of botanic gardens, as well as the German representative in the European Botanic Gardens Consortium. He was also the European representative in the International Association of Botanic Gardens.


Get In Touch

For further information about Terpenia, inquiries about our products and research methods, or for press and other collaboration requests, please get in touch with us either by using the form below or via email.

11 + 10 =

Terpenia® Phytotherapeutics P.C.

Terpenia specializes in cultivating and producing standardized medical cannabis extracts and flowers for the Greek and other European markets.

Our primary emphasis is on the development of finished pharmaceutical formulations, focusing on generating intellectual property.


Get In Touch

Production Facility Greece

Alistrati – Serres
PC 620 45
[email protected]

Consulting Office Germany

Dr. Pavlos Kokordelis
Breite Str. 161-167
50667 Köln
[email protected]

All rights reserved © 2021